220 related articles for article (PubMed ID: 11858475)
1. Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin.
Pettilä V; Leinonen P; Markkola A; Hiilesmaa V; Kaaja R
Thromb Haemost; 2002 Feb; 87(2):182-6. PubMed ID: 11858475
[TBL] [Abstract][Full Text] [Related]
2. The effects of long-term heparin therapy during pregnancy on bone density. A prospective matched cohort study.
Douketis JD; Ginsberg JS; Burrows RF; Duku EK; Webber CE; Brill-Edwards P
Thromb Haemost; 1996 Feb; 75(2):254-7. PubMed ID: 8815571
[TBL] [Abstract][Full Text] [Related]
3. Pregnancy, heparin and osteoporosis.
Schulman S; Hellgren-Wångdahl M
Thromb Haemost; 2002 Feb; 87(2):180-1. PubMed ID: 11858474
[No Abstract] [Full Text] [Related]
4. Prolonged low-molecular-weight heparin use during pregnancy and subsequent bone mineral density.
Galambosi P; Hiilesmaa V; Ulander VM; Laitinen L; Tiitinen A; Kaaja R
Thromb Res; 2016 Jul; 143():122-6. PubMed ID: 27236710
[TBL] [Abstract][Full Text] [Related]
5. Thromboprophylaxis with low molecular weight heparin (dalteparin) in pregnancy.
Pettilä V; Kaaja R; Leinonen P; Ekblad U; Kataja M; Ikkala E
Thromb Res; 1999 Nov; 96(4):275-82. PubMed ID: 10593430
[TBL] [Abstract][Full Text] [Related]
6. Thromboprophylaxis following caesarean section--a comparison of the antithrombotic properties of three low molecular weight heparins--dalteparin, enoxaparin and tinzaparin.
Ellison J; Thomson AJ; Conkie JA; McCall F; Walker D; Greer A
Thromb Haemost; 2001 Dec; 86(6):1374-8. PubMed ID: 11776302
[TBL] [Abstract][Full Text] [Related]
7. Dalteparin versus unfractionated heparin in critically ill patients.
; Cook D; Meade M; Guyatt G; Walter S; Heels-Ansdell D; Warkentin TE; Zytaruk N; Crowther M; Geerts W; Cooper DJ; Vallance S; Qushmaq I; Rocha M; Berwanger O; Vlahakis NE
N Engl J Med; 2011 Apr; 364(14):1305-14. PubMed ID: 21417952
[TBL] [Abstract][Full Text] [Related]
8. Long-term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial.
Rodger MA; Kahn SR; Cranney A; Hodsman A; Kovacs MJ; Clement AM; Lazo-Langner A; Hague WM;
J Thromb Haemost; 2007 Aug; 5(8):1600-6. PubMed ID: 17663731
[TBL] [Abstract][Full Text] [Related]
9. Thromboprophylaxis with low molecular mass heparin, 'Fragmin' (dalteparin), during pregnancy--a longitudinal safety study.
Blombäck M; Bremme K; Hellgren M; Siegbahn A; Lindberg H
Blood Coagul Fibrinolysis; 1998 Jan; 9(1):1-9. PubMed ID: 9607113
[TBL] [Abstract][Full Text] [Related]
10. Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin.
Monreal M; Lafoz E; Olive A; del Rio L; Vedia C
Thromb Haemost; 1994 Jan; 71(1):7-11. PubMed ID: 8165649
[TBL] [Abstract][Full Text] [Related]
11. Postpartum osteoporosis and vertebral fractures in two patients treated with enoxaparin during pregnancy.
Ozdemir D; Tam AA; Dirikoc A; Ersoy R; Cakir B
Osteoporos Int; 2015 Jan; 26(1):415-8. PubMed ID: 25138263
[TBL] [Abstract][Full Text] [Related]
12. Bone density studies in pregnant women receiving heparin.
Shefras J; Farquharson RG
Eur J Obstet Gynecol Reprod Biol; 1996 Apr; 65(2):171-4. PubMed ID: 8730619
[TBL] [Abstract][Full Text] [Related]
13. Thrombosis, thrombophilia, and thromboprophylaxis in pregnancy.
James AH; Brancazio LR; Ortel TL
Clin Adv Hematol Oncol; 2005 Mar; 3(3):187-97. PubMed ID: 16166990
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of unfractionated heparin and the low-molecular-weight heparins dalteparin and enoxaparin on spontaneous platelet aggregation and adenosine diphosphate activity in platelets during the third trimester of pregnancy.
Ajayi AA; Pharmacols FB; Cooper J; Horn EH; Rubin PC
Methods Find Exp Clin Pharmacol; 2007 Oct; 29(8):539-45. PubMed ID: 18040530
[TBL] [Abstract][Full Text] [Related]
15. Management of thromboembolism in pregnancy.
Marks PW
Semin Perinatol; 2007 Aug; 31(4):227-31. PubMed ID: 17825678
[TBL] [Abstract][Full Text] [Related]
16. Thromboprophylaxis with low molecular weight heparin (Fragmin) in high risk pregnancies.
Hunt BJ; Doughty HA; Majumdar G; Copplestone A; Kerslake S; Buchanan N; Hughes G; Khamashta M
Thromb Haemost; 1997 Jan; 77(1):39-43. PubMed ID: 9031446
[TBL] [Abstract][Full Text] [Related]
17. Prospective observational study of bone mineral density during pregnancy: low molecular weight heparin versus control.
Carlin AJ; Farquharson RG; Quenby SM; Topping J; Fraser WD
Hum Reprod; 2004 May; 19(5):1211-4. PubMed ID: 15121733
[TBL] [Abstract][Full Text] [Related]
18. Bone density changes in women who receive thromboprophylaxis in pregnancy.
Casele H; Haney EI; James A; Rosene-Montella K; Carson M
Am J Obstet Gynecol; 2006 Oct; 195(4):1109-13. PubMed ID: 17000242
[TBL] [Abstract][Full Text] [Related]
19. Bone density changes in pregnant women treated with heparin: a prospective, longitudinal study.
Backos M; Rai R; Thomas E; Murphy M; Doré C; Regan L
Hum Reprod; 1999 Nov; 14(11):2876-80. PubMed ID: 10548640
[TBL] [Abstract][Full Text] [Related]
20. Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin.
Dahlman TC
Am J Obstet Gynecol; 1993 Apr; 168(4):1265-70. PubMed ID: 8475973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
